BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 27 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,692 | +23.2% | 4,737,000 | +25.1% | 0.01% | +40.0% |
| Q2 2023 | $3,808 | +20.4% | 3,788,000 | +24.9% | 0.01% | +25.0% |
| Q1 2023 | $3,163 | -41.3% | 3,033,000 | -39.5% | 0.00% | -42.9% |
| Q4 2022 | $5,385 | -99.9% | 5,011,000 | -7.8% | 0.01% | -12.5% |
| Q3 2022 | $5,397,000 | -13.8% | 5,434,000 | -13.8% | 0.01% | 0.0% |
| Q2 2022 | $6,264,000 | -7.1% | 6,303,000 | -6.4% | 0.01% | +14.3% |
| Q1 2022 | $6,743,000 | +6.9% | 6,734,000 | +11.3% | 0.01% | +16.7% |
| Q4 2021 | $6,310,000 | -17.0% | 6,049,000 | -20.3% | 0.01% | -25.0% |
| Q3 2021 | $7,599,000 | -0.1% | 7,593,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $7,608,000 | – | 7,593,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |